Activist Starboard drops out of Celgene fight as proxy firms back Bristol-Myers bid

Activist investor Starboard Value has ended its fight against Bristol-Myers Squibb's buyout of biotechnology company Celgene.

from U.S. News https://ift.tt/2TI6JhN